SLC30A3: A Potential Drug Target for Skin and Wound Healing (G7781)

Target Name: SLC30A3

NCBI ID: G7781

SLC30A3

SLC30A3: A Potential Drug Target for Skin and Wound Healing

SLC30A3 (Simple Localized Correlated Reflectance Change) is a protein that is expressed in various tissues of the body, including the skin, hair, and nails. It is a member of the Tetraspan gene family, which encodes proteins that are involved in the regulation of cell-cell interactions and cytoskeletal organization. SLC30A3 has been shown to play a role in the regulation of cell adhesion and has been identified as a potential drug target in the field of skin and wound healing.

SLC30A3 is a 19kDa protein that is expressed in various tissues of the body, including the skin, hair, and nails. It is characterized by a characteristic monocystic expression pattern, which is characterized by the presence of a single copy of the protein in the cell nucleus and a single copy in the cytoplasm. SLC30A3 is also known for its ability to localize to the pericellular matrix (PCM), which is a structure that is composed of a network of cytoskeletal components that provide support and structure to the cells.

SLC30A3 has been shown to play a role in the regulation of cell adhesion by promoting the formation of tight junctions between adjacent cells. tight junctions are specialized structures that mediate the transfer of electrical and chemical signals between cells and are critical for the regulation of cell- cell interactions. In wounds, SLC30A3 has been shown to promote the formation of tight junctions, which is important for the formation of a barrier that helps to prevent the infiltration of fluid and bacteria into the wound.

SLC30A3 has also been shown to play a role in the regulation of cell proliferation and differentiation. In addition, SLC30A3 has been shown to be involved in the regulation of cell migration and the Maintenance of stem cell properties.

SLC30A3 has also been shown to have potential as a drug target in the field of skin and wound healing. SLC30A3 has been shown to be involved in the regulation of cell adhesion and has been shown to play a role in the formation of tight junctions, which is important for the regulation of cell-cell interactions. This suggests that SLC30A3 may be a useful target for the development of drugs that can promote the formation of tight junctions and improve the healing of wounds.

In conclusion, SLC30A3 is a protein that has been shown to play a role in the regulation of cell adhesion and has been identified as a potential drug target in the field of skin and wound healing. Further research is needed to fully understand the role of SLC30A3 in the regulation of cell interactions and to determine the efficacy of SLC30A3 as a drug.

Protein Name: Solute Carrier Family 30 Member 3

Functions: Probable proton-coupled zinc ion antiporter mediating the import of zinc from cytoplasm into synaptic vesicles and participating to cellular zinc ion homeostasis in the brain

The "SLC30A3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SLC30A3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets